Journal
BIOCHEMICAL JOURNAL
Volume 440, Issue -, Pages 175-183Publisher
PORTLAND PRESS LTD
DOI: 10.1042/BJ20111333
Keywords
drug resistance; glutathione; glutathione transferase P1-1 (GSTP1-1); histones; nitric oxide (NO); tumour cell
Categories
Funding
- Italian Ministry for Education, University and Research, General Management for international research
- Programma Oncotecnologico Convenzione Istituto Superiore di Sanita [501/A3/12]
- PRIN
Ask authors/readers for more resources
Acquired drug resistance was found to be suppressed in the doxorubicin-resistant breast cancer cell line MCF7/Dx after pre-treatment with GSNO (nitrosoglutathione). The effect was accompanied by enhanced protein glutathionylation and accumulation of doxorubicin in the nucleus. Among the glutathionylated proteins, we identified three members of the histone family; this is, to our knowledge, the first time that histone glutathionylation has been reported. Formation of the potential NO donor dinitrosyl diglutathionyl iron complex, bound to GSTP1-1 (glutathione transferase P1-1), was observed in both MCF7/Dx cells and drug-sensitive MCF7 cells to a similar extent. In contrast, histone glutathionylation was found to be markedly increased in the resistant MCF7/Dx cells, which also showed a 14-fold higher amount of GSTP1-1 and increased glutathione concentration compared with MCF7 cells. These results suggest that the increased cytotoxic effect of combined doxorubicin and GSNO treatment involves the glutathionylation of histones through a mechanism that requires high glutathione levels and increased expression of GSTP1-1. Owing to the critical role of histones in the regulation of gene expression, the implication of this finding may go beyond the phenomenon of doxorubicin resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available